Columbus Venture Partners is a Spanish independent venture capital firm focused on investing in early-stage and high-growth opportunities within the life sciences sector, particularly in biotechnology and health sciences. The firm supports innovative science emerging from research centers and startups, guiding them through development to commercialization of new products and treatments addressing unmet medical needs. Since its inception in 2016, Columbus VP has launched four funds, managing a total of €400 million, and has made 27 investments with a dozen successful exits, including companies like Askbio, Viralgen, PTS, and Sanifit.
Is Columbus Venture Partners the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Columbus Venture Partners, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
€3,000,000 - €20,000,000
When approaching Columbus Venture Partners, founders should highlight the scientific rigor and translational potential of their technology, especially if it addresses a clear unmet medical need. Demonstrating strong ties to leading research institutions or a robust pipeline with early validation data can help establish credibility. Columbus values teams with deep domain expertise and a clear path to clinical or commercial milestones, so be prepared to articulate your development roadmap and how their support could accelerate your journey from lab to market.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.